Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices of Intent to Publish

Notice of Intent to Publish an NHLBI Funding Opportunity Announcement for STIMULATE-2 (R61/R33 Clinical Trial Required)

(NOT-HL-19-715) National Heart, Lung, and Blood Institute

Funding Opportunities

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) (PAR-19-329) National Heart, Lung, and Blood Institute Application Receipt Date(s): New and Revision Applications: October 11, 2019, February 11, 2020, June 10, 2020, October 14, 2020, February 11, 2021, June 10, 2021, October 14, 2021, February 11, 2022, June 10, 2022 by 5:00 PM local time of applicant organization. Resubmission Applications: November 12, 2019, March 11, 2020, July 10, 2020, November 17, 2020, March 11, 2021, July 13, 2021, November 15, 2021, March 11, 2022, July 11, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applications must be submitted for the same due date as the collaborating DCC application.

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) (PAR-19-330) National Heart, Lung, and Blood Institute Application Receipt Date(s): New and Revision Applications: October 11, 2019, February 11, 2020, June 10, 2020, October 14, 2020, February 11, 2021, June 10, 2021, October 14, 2021, February 11, 2022, June 10, 2022 by 5:00 PM local time of applicant organization. Resubmission Applications: November 12, 2019, March 11, 2020, July 10, 2020, November 17, 2020, March 11, 2021, July 13, 2021, November 15, 2021, March 11, 2022, July 11, 2022 by 5:00 PM local time of applicant organization. Applications must be submitted for the same due date as the collaborating CCC (UG3/UH3) application.

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed

(PAR-19-333) National Institute on Aging National Eye Institute

National Heart, Lung, and Blood Institute

National Institute on Alcohol Abuse and Alcoholism

National Institute of Allergy and Infectious Diseases

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of General Medical Sciences

National Institute of Mental Health

National Institute of Neurological Disorders and Stroke

Application Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed

(PAR-19-334) National Institute on Aging

National Center for Advancing Translational Sciences

National Cancer Institute

National Eye Institute

National Human Genome Research Institute

National Heart, Lung, and Blood Institute

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Biomedical Imaging and Bioengineering

National Institute on Deafness and Other Communication Disorders